MERGERS AND ACQUISITIONS Wilson Wolf Corp., New Brighton, has entered into an asset purchase agreement with Wheaton under which Wheaton has acquired the Cellline Bioreactor Flask product line and will commercialize other Wilson Wolf technology directed at the production of cell-secreted proteins such as antibody and recombinant protein.
The Latest
16 minutes ago
‘He’s going to play a lot’: A new face arrives at Twins camp as the starting first baseman 35 minutes ago
Anderson: Casting an eye south, to Belize, in winter1 Hour ago
A 23-year-old man stabbed 6 people in Austria killing 1 in what police describe as a random attack1 Hour ago
Rwanda-backed rebels advance and Congolese forces retreat from eastern Congo's second largest city2 Hours ago
Israel and Hamas complete their latest exchange as ceasefire's first phase has just 2 weeks left2 Hours ago
Zelenskyy calls for 'armed forces of Europe' as EU leaders bristle at new US policies on Ukraine3 Hours ago
Justice Department fires 20 immigration judges from backlogged courts amid major government cuts4 Hours ago
St. Paul garage fire victims identified about the writer
More from Business
See More
At the center of the potential post-pandemic rebound is the Kickernick Building and its new owner’s gallery.
The financial services giant Vanguard recently announced it was cutting fees on its investment products, which it said would save its investors more than $350 million in 2025 alone.
From understanding your fees to being mindful of taxes, there are several simple ways to ensure your money is in its best position.
At the center of the potential post-pandemic rebound is the Kickernick Building and its new owner’s gallery.